• Join
  • Login
  • Contact

Search abstracts

The Effect of Community Pharmacist Prescribing and Care on Cardiovascular Risk Reduction: The RxEACH Multicentre Randomized Controlled Trial

  • At: 2016 FIP Congress in Buenos Aires (Argentina)
  • Type: Presentation
  • By: TSUYUKI, Ross (Faculty of Medicine and Dentistry, University of Alberta, Department of Medicine/Cardiology, Edmonton, Canada)
  • Co-author(s): Ross Tsuyuki:|Yazid Al Hamarneh:Medicine/Cardiology,University of Alberta,Edmonton,Canada|Charlotte Jones:Medicine,Southern Medical Program, University of British Columbia,Kelowna,Canada|Brenda Hemmelgarn:Community Health Sciences/Medicine,University of Calgary,Calgary,Canada
  • Abstract:

    The cardiovascular disease (CVD) risk factors hypertension, diabetes, dyslipidemia, and smoking remain poorly identified and controlled. 

    RxEACH was a per patient randomized controlled trial conducted in 56 community pharmacies in Alberta, Canada.

    Population: High risk adults with diabetes, chronic kidney disease, vascular disease, or Framingham


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses